相关实验视频
Updated: Jun 3, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
激素脱乙酶抑制剂的抗癌特性 - 它们的潜力是什么?
Kajetan Kiełbowski1,2, Agata Szwedkowicz1, Paulina Plewa1
1Department of Physiology, Pomeranian Medical University, Szczecin, Poland.
Expert review of anticancer therapy
|January 10, 2025
概括
基斯脱乙酶 (HDAC) 抑制剂在癌症治疗中表现有前途. 将这些表观遗传药物与其他疗法结合起来,可能会改善患者的治疗结果,并增强癌细胞对治疗的敏感性.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 包括乙化在内的质子修饰是基因表达的关键表观遗传调节剂.
- 基因组脱乙酶 (HDACs) 控制基因组乙化,影响基因转录.
- 向激素乙化已经成为癌症治疗的可行策略,已批准了几种HDAC抑制剂.
研究的目的:
- 审查已批准和新型HDAC抑制剂的抗癌疗效.
- 探索HDAC抑制剂在联合癌症治疗中的潜力.
主要方法:
- 进行了全面的文献审查.
- 通过使用PubMed数据库来确定研究.
- 该审查的重点是评估HDAC抑制剂的抗癌疗效.
主要成果:
- 有证据表明,HDAC抑制剂是有效的抗癌剂.
- 将HDAC抑制剂与其他抗癌剂结合起来显示出有前途的益处.
- HDAC 抑制剂可能会增强癌细胞对化疗和向疗法的敏感性.
结论:
- HDAC 抑制剂在瘤学中代表着一个重要的治疗途径.
- 涉及HDAC抑制剂的组合疗法需要进一步研究.
- 未来的研究应该优化组合策略,以提高有效性和安全性.
相关概念视频
Histone Modification
13.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
404
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
404
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K

